PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
2 hedge funds and large institutions have $1.47M invested in PureTech Health in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
0.2% less ownership
Funds ownership: 0.21% → 0.01% (-0.2%)
50% less funds holding
Funds holding: 4 → 2 (-2)
70% less capital invested
Capital invested by funds: $4.9M → $1.47M (-$3.42M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| 1 |
BHIA
Birch Hill Investment Advisors
Boston,
Massachusetts
|
-$1.67M |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
-$1.45M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.55K |
PRTC Hedge Fund Activity: Q2 2021 in Review
2 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q2 2021, worth a combined $1.47M — down 70% from $4.9M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PRTC and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Birch Hill Investment Advisors, exiting entirely with an estimated $1.67M sold.
- 2 institutional investors held PureTech Health (PRTC) as of Q2 2021, down from 4 in Q1 2021.
- Funds reported $1.47M of PureTech Health stock for Q2 2021, down 70% quarter-over-quarter.
- 0 funds opened new PureTech Health positions in Q2 2021 and 2 closed out, a net change of -2 holders.
- The largest PureTech Health seller in Q2 2021 was Birch Hill Investment Advisors, an estimated $1.67M sold.
Based on aggregated 13F filings for Q2 2021.